Auteurs
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Corpus (PubMed)

Index « Auteurs » - entrée « Mark A. Boyd »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mark A. Baker < Mark A. Boyd < Mark A. Clark  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000031 (2017) Mark A. Boyd ; Amanda Mocroft ; Lene Ryom ; Antonella D'Arminio Monforte ; Caroline Sabin ; Wafaa M. El-Sadr ; Camilla Ingrid Hatleberg ; Stephane De Wit ; Rainer Weber ; Eric Fontas ; Andrew Phillips ; Fabrice Bonnet ; Peter Reiss ; Jens Lundgren ; Matthew LawCardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
000D50 (2017) Amanda H. Yao ; Cecilia L. Moore ; Poh Lian Lim ; Jean-Michel Molina ; Juan Sierra Madero ; Stephen Kerr ; Paddy Wg Mallon ; Sean Emery ; David A. Cooper ; Mark A. BoydMetabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.
000D74 (2017) Soo-Yon Rhee ; Vici Varghese ; Susan P. Holmes ; Gert U. Van Zyl ; Kim Steegen ; Mark A. Boyd ; David A. Cooper ; Sabin Nsanzimana ; Shanmugam Saravanan ; Charlotte Charpentier ; Tulio De Oliveira ; Mary-Ann A. Etiebet ; Federico Garcia ; Dominique Goedhals ; Perpetua Gomes ; Huldrych F. Günthard ; Raph L. Hamers ; Christopher J. Hoffmann ; Gillian Hunt ; Awachana Jiamsakul ; Pontiano Kaleebu ; Phyllis Kanki ; Rami Kantor ; Bernhard Kerschberger ; Vincent C. Marconi ; Jean D'Amour Ndahimana ; Nicaise Ndembi ; Nicole Ngo-Giang-Huong ; Casper Rokx ; Maria M. Santoro ; Jonathan M. Schapiro ; Daniel Schmidt ; Lillian Seu ; Kim C E. Sigaloff ; Sunee Sirivichayakul ; Lindiwe Skhosana ; Henry Sunpath ; Michele Tang ; Chunfu Yang ; Sergio Carmona ; Ravindra K. Gupta ; Robert W. ShaferMutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.
001359 (2017) Mark A. Boyd ; Janaki Amin ; Patrick W G. Mallon ; Nagalingeswaran Kumarasamy ; Johan Lombaard ; Robin Wood ; Ploenchan Chetchotisakd ; Praphan Phanuphak ; Lerato Mohapi ; Iskandar Azwa ; Waldo H. Belloso ; Jean-Michel Molina ; Jennifer Hoy ; Cecilia L. Moore ; Sean Emery ; David A. CooperBody composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
001707 (2016) John Zaunders ; Mark Danta ; Michelle Bailey ; Gerald Mak ; Katherine Marks ; Nabila Seddiki ; Yin Xu ; David J. Templeton ; David A. Cooper ; Mark A. Boyd ; Anthony D. Kelleher ; Kersten K. KoelschCD4(+) T Follicular Helper and IgA(+) B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals.
001976 (2016) Edward P. Lam ; Cecilia L. Moore ; Eduardo Gotuzzo ; Chidi Nwizu ; Adeeba Kamarulzaman ; Ploenchan Chetchotisakd ; Jean Van Wyk ; Hedy Teppler ; Nagalingeswaran Kumarasamy ; Jean-Michel Molina ; Sean Emery ; David A. Cooper ; Mark A. BoydAntiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
002F98 (2015) Janaki Amin ; Mark A. Boyd ; Nagalingeswaran Kumarasamy ; Cecilia L. Moore ; Marcello H. Losso ; Chidi A. Nwizu ; Lerato Mohapi ; Stephen J. Kerr ; Annette H. Sohn ; Hedy Teppler ; Boris Renjifo ; Jean-Michel Molina ; Sean Emery ; David A. CooperRaltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection.
003039 (2015) Mark A. Boyd ; Cecilia L. Moore ; Jean-Michel Molina ; Robin Wood ; Juan S. Madero ; Marcelo Wolff ; Kiat Ruxrungtham ; Marcelo Losso ; Boris Renjifo ; Hedy Teppler ; Anthony D. Kelleher ; Janaki Amin ; Sean Emery ; David A. CooperBaseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
003438 (2014) Hila Haskelberg ; Patrick W G. Mallon ; Jennifer Hoy ; Janaki Amin ; Cecilia Moore ; Praphan Phanuphak ; Samuel Ferret ; Waldo H. Belloso ; Mark A. Boyd ; David A. Cooper ; Sean EmeryBone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy.
003B28 (2013) Allison Martin ; Cecilia Moore ; Patrick W G. Mallon ; Jennifer Hoy ; Sean Emery ; Waldo Belloso ; Praphan Phanuphak ; Samuel Ferret ; David A. Cooper ; Mark A. BoydBone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i -k "Mark A. Boyd" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i  \
                -Sk "Mark A. Boyd" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Mark A. Boyd
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024